Key result
Diabetes mortality rose despite glycemic improvements in the Samara region, with T2D deaths up ~45%.
Why the study?
Trend analysis of epidemiological and clinical characteristics of diabetes mellitus patients in the Samara region during the initial spread of COVID-19 can help assess medical care effectiveness and guide improvements.
Comparison
Trends in prevalence, incidence, mortality, vascular complications, and glycemic control from 2018 to 2020
Design
Continuous retrospective observational study
Follow-up
2018 to 2020
Authors
Loading...
Rising diabetes mortality in Samara 2018-2020 despite better control; leaves open pandemic or regional drivers in this observational cohort.
Observational (n=118,623)
This epidemiological study highlights increasing mortality and changing glycemic control trends among diabetes patients in the Samara region during the initial COVID-19 pandemic period, with cardiovascular disease remaining the leading cause of death.
Pervyshin et al. (2023) conducted an observational in Diabetes mellitus (n=118,623). Time period (2018-2020) was evaluated on Trends in prevalence, incidence, and mortality. From 2018 to 2020 in the Samara region, mortality increased for type 1 (3.2 to 4.2/100,000) and type 2 diabetes (120.7 to 174.5/100,000), while the proportion of patients with HbA1c <7% improved.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: